Key result
KCNQ1 N-terminal mutations (Y111C, L114P, P117L) associated with LQT1 syndrome fail to exit the endoplasmic reticulum, preventing plasma membrane trafficking and exerting a dominant negative effect.
The N-terminal juxtamembranous domain of KCNQ1 is a critical trafficking determinant, and mutations in this region cause severe LQT1 syndrome by preventing channel surface expression.
ER retention of mutant KCNQ1 may drive severe LQT1; hypothesis-generating for trafficking-targeted therapies pending human validation.
N-terminal mutations in the KCNQ1 channel are frequently linked to fatal arrhythmias in newborn children and adolescents but the cellular mechanisms involved in this dramatic issue remain, however, to be discovered. Here, we analyzed the trafficking of a series of N-terminal truncation mutants and identified a critical trafficking motif of KCNQ1. This determinant is located in the juxtamembranous region preceding the first transmembrane domain of the protein. Three mutations (Y111C, L114P and P117L) implicated in inherited Romano-Ward LQT1 syndrome, are embedded within this domain. Reexpression studies in both COS-7 cells and cardiomyocytes showed that the mutant proteins fail to exit the endoplasmic reticulum. KCNQ1 subunits harboring Y111C or L114P exert a dominant negative effect on the wild-type KCNQ1 subunit by preventing plasma membrane trafficking of heteromultimeric channels. The P117L mutation had a less pronounced effect on the trafficking of heteromultimeric channels but altered the kinetics of the current. Furthermore, we showed that the trafficking determinant in KCNQ1 is structurally and functionally conserved in other KCNQ channels and constitutes a critical trafficking determinant of the KCNQ channel family. Computed structural predictions correlated the potential structural changes introduced by the mutations with impaired protein trafficking. In conclusion, our studies unveiled a new role of the N-terminus of KCNQ channels in their trafficking and its implication in severe forms of LQT1 syndrome.
No takes yet. Share an insight, caveat, or question.
Dahimène et al. (2006) studied Romano-Ward LQT1 syndrome. KCNQ1 N-terminal mutations (Y111C, L114P, P117L) vs. Wild-type KCNQ1 was evaluated on Channel surface expression and trafficking. KCNQ1 N-terminal mutations (Y111C, L114P, P117L) associated with LQT1 syndrome fail to exit the endoplasmic reticulum, preventing plasma membrane trafficking and exerting a dominant negative effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: